Table 1.
Characteristics of FHS Offspring Participants at Examination 7 Who Did (n=1776) and Did Not (n=1763) Undergo CMR
| Clinical Characteristic (Examination 7) | No CMR (n=1763) | CMR (n=1776) |
|---|---|---|
| Age, y | 63±10 | 60±9 |
| Male sex, n (%) | 790 (45) | 835 (47) |
| Body mass index, kg/m2 | 28.5±5.7 | 27.9±4.9 |
| Body surface area, kg/m2 | 1.9±0.3 | 1.9±0.2 |
| Systolic blood pressure, mm Hg | 130±20 | 125±18 |
| Use of antihypertensive meds, n (%) | 700 (40) | 518 (29) |
| Diabetes, n (%) | 241 (15) | 154 (9) |
| Dyslipidemia, n (%) | 1005 (64) | 1087 (62) |
| Current smoking, n (%) | 299 (17) | 184 (10) |
| Estimated glomerular filtration rate, mL/min/1.73 m2 | 84±20 | 86±18 |
Continuous data presented as mean±SD, and categorical data presented as n (%). Clinical characteristics from examination 7. Diabetes: fasting glucose ≥126 mg/dL or the use of hypoglycemic medications. Dyslipidemia: total cholesterol ≥200 mg/dL or the use of lipid-lowering medications. Estimated glomerular filtration rate by Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation. CMR indicates cardiovascular magnetic resonance; FHS, Framingham Heart Study.